Results for tag: "Salivary Gland Cancer Drug"

The Salivary Gland Cancer Drug market is a subset of the larger Oncology Drugs market. It is composed of drugs used to treat salivary gland cancer, a rare type of cancer that affects the salivary glands. These drugs are used to reduce the size of tumors, reduce symptoms, and improve the quality of life of patients. Common treatments include chemotherapy, radiation therapy, and targeted therapy. The Salivary Gland Cancer Drug market is highly competitive, with many companies offering innovative treatments. Some of the major players in the market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. These companies are constantly developing new treatments to improve the lives of patients with salivary gland cancer. Show Less Read more